Literature DB >> 16898903

Prevalence and predictors of psychosocial morbidity in patients with chronic pruritic skin diseases.

H van Os-Medendorp1, P C M Eland-de Kok, M Grypdonck, C A F M Bruijnzeel-Koomen, W J G Ros.   

Abstract

BACKGROUND: Itch is a major symptom of many skin diseases and causes patients considerable distress, adversely affecting quality of life. Feelings of helplessness and lack of control can influence the perceived itch and psychosocial complaints.
OBJECTIVES: To determine the prevalence of psychosocial morbidity among patients with pruritic skin diseases, and the influence of itch-related variables, coping strategies, and demographic variables on psychosocial morbidity. PATIENTS AND METHODS: One hundred and sixty-eight patients with pruritic skin diseases from five hospitals in the Netherlands participated in the study. Skin-related psychosocial morbidity was measured with the Adjustment to Chronic Skin Diseases questionnaire (ACS); general psychosocial morbidity was measured with the Symptom Checklist-90 (SCL-90). The frequency and intensity of itching and scratching was recorded in diaries. Itch-related coping was measured with the Itching Cognitions Questionnaire (ICQ). Multiple regression analyses were used.
RESULTS: Patients with pruritic skin diseases had higher SCL-90 scores than a healthy Dutch population. All patients had psychosocial complaints as measured with the ACS. Thirty-nine per cent of the variance in skin-related psychosocial morbidity was explained by 'catastrophizing and helpless coping'; another 11% was explained by itching and scratching. Age and sex together explained another 10%. The frequency of itching and scratching (11%), 'catastrophizing and helpless coping' (19%) and skin-related psychosocial morbidity (10%) explained the variance in general psychosocial morbidity.
CONCLUSIONS: Patients with a pruritic skin disease have a high level of psychosocial morbidity. Catastrophizing and helpless coping are the most important predictors of psychosocial morbidity, with itching, scratching and demographic variables having a limited influence.

Entities:  

Mesh:

Year:  2006        PMID: 16898903     DOI: 10.1111/j.1468-3083.2006.01647.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  8 in total

Review 1.  Management of itch in atopic dermatitis.

Authors:  Judith Hong; Joerg Buddenkotte; Timothy G Berger; Martin Steinhoff
Journal:  Semin Cutan Med Surg       Date:  2011-06

2.  [The association of unwanted drug effects and increased psychovegetative lability].

Authors:  K Seikowski; D Barth; A Majer; R Treudler
Journal:  Hautarzt       Date:  2013-06       Impact factor: 0.751

3.  Neurobehavioral profiles in individuals with hyperimmunoglobulin E Syndrome (HIES) and brain white matter hyperintensities.

Authors:  Staci Martin; Pamela Wolters; Nia Billings; Mary Anne Toledo-Tamula; Dima A Hammoud; Pamela Welch; Dirk Darnell; Steven M Holland; Alexandra F Freeman
Journal:  J Clin Immunol       Date:  2013-08-21       Impact factor: 8.317

Review 4.  Psychogenic itch.

Authors:  Laurent Misery; Sabine Dutray; Myriam Chastaing; Martine Schollhammer; Sylvie G Consoli; Silla M Consoli
Journal:  Transl Psychiatry       Date:  2018-03-01       Impact factor: 6.222

5.  Pruriplastic Itch-A Novel Pathogenic Concept in Chronic Pruritus.

Authors:  Laurent Misery
Journal:  Front Med (Lausanne)       Date:  2021-01-20

6.  Effect of the pruritus on the quality of life: a preliminary study.

Authors:  Irem Eren Erturk; Ozer Arican; Imran Kurt Omurlu; Necdet Sut
Journal:  Ann Dermatol       Date:  2012-11-08       Impact factor: 1.444

7.  Prurigo nodularis: a physician survey to evaluate current perceptions of its classification, clinical experience and unmet need.

Authors:  M P Pereira; S Basta; J Moore; S Ständer
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-07-01       Impact factor: 6.166

8.  Development and psychometrics of the English version of the Itch Cognitions Questionnaire.

Authors:  Carolyn J Heckman; Christina Schut; Mary Riley; Anke Ehlers; Rodrigo Valdes-Rodriguez; Jörg Kupfer; Uwe Gieler; Jerod L Stapleton
Journal:  PLoS One       Date:  2020-03-19       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.